RE:RE:RE:Keep Your Eye on the Ball ! The notes taken from the recent AGM make clear that the FDA "insisted" that the company's Phase II data be confirmed via an FDA approved Central Lab...much to the apparent annoyance of the CEO. However, Mr White was candid in concluding that it is the FDA who makes the rules.
For the company, just a few days after the AGM, to publish its current extraordinary findings as it did this morning one would logically assume that this data has been confirmed and supported not only by the company but by the FDA via its Central Lab.
But, I have to think you already knew this.
Why am I responding to this guy?!